89bio slides on stock offering to fund MASH drug
** Shares of 89Bio ETNB.O down 6.2% post-market to $8.44
as co looks to raise equity
** ETNB shares
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))